Grail
Company ● Covered in 1 story + Follow ✴ AI Graph
This profile is built automatically from TLDRocket coverage.
Signals
1 story (new)
Media momentum
As of 24 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.
1 source
Source diversity
As of 24 Sep 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 24 Sep 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 24 Sep 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Sep 2026
Coverage span
As of 24 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.
Management
updated 24 Sep 2026- Bob Ragusa Senior Executive Advisor
- Lakshman Ramamurthy Vice President Regulatory Affairs
- Lisa Anderson Director, Quality Systems
- Jeffrey Catania Senior Director Regulatory Affairs Companion Diagnostics CDx, MCED & International at GRAIL
- Pooja Gandhi Director, Clinical Quality Assurance
- Sheri Langerman Senior Director, Sustaining, Post Market, & Operations Quality
- Nandan Nabar Ms, Mba, Pmp, Csm Senior Director, Design Control, Risk Management And Quality Engineering
- Joshua Ofman President
- Paul Ciccolella Senior Vice President, Global Technology & Operations
- Dennis Lo Scientific Advisor
- Timothy R. Church Scientific Advisor
- William N. Hait Scientific Advisor
+ 12 more tracked
Latest developments
September 2026
Relationships
Products & technology
- Deploys FDA advisory committee · 1 source
- Deploys U.S. Food and Drug Administration · 1 source